Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
---|
11/15/2001 | US20010041670 Activity of thrombospondin (TSP-1), an antiangiogenic protein, can be modulated by stimulating or inhibiting the activity of Histidine-Rich Glycoprotein (HRGP) or a protein that includes thrombospondin binding motif of HRGP |
11/15/2001 | US20010041348 Animal sperm cell membrane |
11/15/2001 | US20010041179 Immunosuppression with monoclonal antibodies specific for interleukin-2 receptor |
11/15/2001 | DE10022362A1 Verfahren zum Auffinden von Modulatoren von Enzymen des Carotenoid-Biosyntheseweges A method for finding modulators of enzymes of the carotenoid biosynthesis pathway |
11/15/2001 | CA2768046A1 Nucleic acid molecules encoding plant cell cycle proteins and uses therefor |
11/15/2001 | CA2411244A1 Therapeutic pore-forming peptides |
11/15/2001 | CA2409515A1 Human igm antibodies with the capability of inducing remyelination, and diagnostic and therapeutic uses thereof particularly in the central nervous system |
11/15/2001 | CA2409150A1 Compositions and methods for the diagnosis, treatment and prevention of steroid hormone responsive cancers |
11/15/2001 | CA2408921A1 Modified inosine 5'-monophosphate dehydrogenase polypeptides and uses thereof |
11/15/2001 | CA2408828A1 Novel serine-threonine kinase-4 |
11/15/2001 | CA2408738A1 Virulence genes, proteins, and their use |
11/15/2001 | CA2408732A1 Modified es cells and es cell-specific gene |
11/15/2001 | CA2408665A1 Novel regulator of g protein signalling |
11/15/2001 | CA2408664A1 F-box containing protein |
11/15/2001 | CA2408632A1 Ph domain-interacting protein |
11/15/2001 | CA2408594A1 Human monoclonal antibodies to dendritic cells |
11/15/2001 | CA2408576A1 Rh116 polypeptides and its fragments and polynucleotides encoding said polypeptides and therapeutic uses |
11/15/2001 | CA2408571A1 Mammalian receptor proteins; related reagents and methods |
11/15/2001 | CA2408559A1 Polynucleotides encoding for polymorphic isoforms of the pthrp protein, the encoded proteins and their therapeutic applications thereof |
11/15/2001 | CA2408549A1 Therapeutic method and composition utilizing antigen-antibody complexation and presentation by dendritic cells |
11/15/2001 | CA2408547A1 Therapeutic method and composition utilizing antigen-antibody complexation and presentation by dendritic cells |
11/15/2001 | CA2408468A1 Serine-threonine kinase-3 |
11/15/2001 | CA2408349A1 Method of regulating angiogenesis unsing ryk protein |
11/15/2001 | CA2408297A1 Cancer diagnosis and assays for screening anti-cancer agents |
11/15/2001 | CA2408213A1 Protein complexes and assays for screening anti-cancer agents |
11/15/2001 | CA2408051A1 Nucleotide sequences involved in increasing or decreasing mammalian ovulation rate |
11/15/2001 | CA2408038A1 Nucleic acid molecules encoding plant cell cycle proteins and uses therefor |
11/15/2001 | CA2408002A1 Enzymatic assays for screening anti-cancer agents |
11/15/2001 | CA2407937A1 New ras guanine-nucleotide-exchange factor 1 (nrg1) |
11/15/2001 | CA2407886A1 Production of adenine nucleotide translocator (ant), novel ant ligands and screening assays therefor |
11/15/2001 | CA2407864A1 Lipid metabolism enzymes |
11/15/2001 | CA2407858A1 Use of inhibitors of placental growth factor for the treatment of pathological angiogenesis, pathological arteriogenesis, inflammation, tumour formation and/or vascular leakage |
11/15/2001 | CA2407850A1 Cytoskeleton-associated proteins |
11/15/2001 | CA2406644A1 Sentinel virus ii |
11/15/2001 | CA2405694A1 Separation of avian antibodies |
11/14/2001 | EP1154019A2 G-protein coupled receptor (HFGAN72X) |
11/14/2001 | EP1153611A2 Pharmaceutical composition for the treatment of fibrosis |
11/14/2001 | EP1153133A2 Human diacylglycerol kinase beta (hdagk beta) proteins and nucleotide sequences encoding the same |
11/14/2001 | EP1153039A2 Use of blocking anti-tsh-receptor-antibodies in the therapy of hyperthyreoses and monoclonal antibodies for a use of this type |
11/14/2001 | EP1153035A2 Human lipid-associated proteins |
11/14/2001 | EP1152771A2 Adjuvant and cell maturation agent |
11/14/2001 | EP1152769A1 Yeast cell wall peptides and antibodies thereto |
11/14/2001 | EP1152752A1 Methods for preventing graft rejection and ischemia-reperfusion injury |
11/14/2001 | EP0845998B1 Immunotherapy medicaments containing antibodies which specifically detect the mhcii antigen of a patient to be treated |
11/14/2001 | EP0715653B1 Humanised antibodies |
11/14/2001 | EP0712307B1 Methods for b-cell population control |
11/14/2001 | EP0688360B1 Bone stimulating factor |
11/14/2001 | EP0656010B8 Use of peptides causing a immune response for the preparation of medicaments to induce the suppression of the immune reaction. |
11/14/2001 | EP0546110B1 New insulin-like growth factor binding protein igfbp-5 |
11/14/2001 | EP0546074B1 Genetic material encoding igfbp-5 |
11/14/2001 | CN1322251A Mutant human hepatitis B viral strain and uses thepeof |
11/14/2001 | CN1322249A Neiseria meningitidis antigenic polypeptides, corresponding polynucleotides and protective antibodies |
11/14/2001 | CN1322248A Plant disease resistance signalling gene, mateirals and methods relating thereto |
11/14/2001 | CN1322246A Restin and methods of use thereof |
11/14/2001 | CN1322244A Tumor necrosis factor-gamma |
11/14/2001 | CN1322214A Induction of antiobiotic proteins and peptides by LAIT/sCD14-protein |
11/14/2001 | CN1321760A Novel polypeptide-human striatum concentrated phosphatase (STEP) 11 and polynucleotide for coding this polypeptide |
11/14/2001 | CN1321759A Novel polypetpide-human uridylic acid kinase 11 and polynucleotide for coding for polypeptide |
11/14/2001 | CN1321754A Novel polypeptide-human YSK 1 protein kinase 14 and polynucleotide for coding this polypeptide |
11/14/2001 | CN1321749A Novel polypeptid-human tyrosinase 8 and polynucleotide for coding this polypeptide |
11/14/2001 | CN1321745A Macrophage inflammatory protein -3, -4 and -1 gamma |
11/14/2001 | CN1321688A Novel polypeptide-human zinc finger protein 60 and polynucleotide for coding this polypeptide |
11/14/2001 | CN1321687A Novel polypeptide-central cannabis receptor 11 and polynucleotide for coding this polypeptide |
11/14/2001 | CN1321686A Novel polypeptide-human myb protein 41 and polynucleotide for coding this polypeptide |
11/14/2001 | CN1321685A Novel polypeptide-human DNA bindin RFX2-89 and polynucleotide for coding this polypeptide |
11/14/2001 | CN1321683A Novel polypeptide-human Pax protein 10.1 and polynucleotide for coding this polypeptide |
11/14/2001 | CN1321682A Novel polypeptide-human phosphatidase 11 and polynucleotide for coding this polypeptide |
11/14/2001 | CN1321671A Novel polypeptide-human ribosomal protein 13 and polynucleotide for coding this polypeptide |
11/14/2001 | CN1321667A Novel polypeptide-human chicken wing deformation protein FH2-23 and polynucleotide for coding this polypeptide |
11/14/2001 | CN1321665A Novel polypeptide-human thyroglobulin 38 and polynucleotide for coding this polypeptide |
11/14/2001 | CN1321651A Novel-polypeptide-human kingle protein 15 and polynucleotide for coding this polypeptide |
11/14/2001 | CN1321649A Novel polypeptide-central cannabis receptor 10 and polynucleotide for coding this polypeptide |
11/13/2001 | US6316611 Human N-methyl-D-aspartate receptor subunits, nucleic acids encoding same and uses therefor |
11/13/2001 | US6316609 Nucleotide sequence of Escherichia coli pathogenicity islands |
11/13/2001 | US6316601 Antibodies specific for β6 integrins |
11/13/2001 | US6316600 Generating monoclonal antibodies; immunize poultry, isolate and immortalize lymphocytes, transform with vector, culture cells, recover antibodies |
11/13/2001 | US6316599 Preferential antibody for use in the diagnosis and detection and treatment of tumors |
11/13/2001 | US6316420 Immunization against multiple sclerosis with administering to subject a naked dna nucleic acid construct encoding a cytokine |
11/13/2001 | US6316412 Polypeptides for promoting cell attachment |
11/13/2001 | US6316408 Methods of use for osetoprotegerin binding protein receptors |
11/13/2001 | US6316403 Deactivation of factor ix for coagulation inhibition and antiischemic agents |
11/13/2001 | US6316258 Inhibiting angiotensin/renin induced generation of transforming growth factor; mix renin with modulator and sample, incubate, evaluate sample for reduced generation of transforming growth factor |
11/13/2001 | US6316257 Generating preferential blood cells in culture; mix blood cells, activators and interleukins, incubate evaluate cell amplification |
11/13/2001 | US6316239 HKABY60 kinase family polypeptides |
11/13/2001 | US6316237 Respiratory nitrate reductase alpha subunit |
11/13/2001 | US6316227 Dna sequence encoding a composite heavy chain of a recombinant antibody molecule that specifically binds human interleukin-5 antigen |
11/13/2001 | US6316226 For use in treatment of hemophilia a |
11/13/2001 | US6316222 Binds calcium-signal modulating cyclophilin ligand; use in identifying agents for modulating the calcium induced activation pathway |
11/13/2001 | US6316219 Compounds |
11/13/2001 | US6316218 Nucleotide sequences coding antispasmodic agent; for treatment of peptic ulcer and inflammatory bowel diseases |
11/13/2001 | US6316217 Activin receptor-like kinases, proteins having serine threonine kinase domains and polynucleotides encoding same |
11/13/2001 | US6316007 Combined physical and immunotherapy for cancer |
11/13/2001 | US6315998 Administering anti-cd40 monoclonal antibody or an antigen binding fragment which is being free of significant agonistic activity and binding to a human cd40 antigen located on surface of a human b cell prevents growth or differentiation |
11/13/2001 | US6315997 Administering modified antibody which selectively binds human milk fat globule (hmfg) antigen, and competes as well or better with unmodified unmodified antibody for binding the hfmg for reducing tumor growth or reducing size of tumor |
11/13/2001 | US6315995 Adding to blood inactive recombinant mutein comprising proteolytically inactive mutein of factor ix or ixa to inhibit clot formation, does not interfere with hemostasis when the blood is administered to a patient |
11/13/2001 | CA2303505C A monoclonal antibody against estrogen stimulated leucine aminopeptidase |
11/08/2001 | WO2001084158A1 Use of the g protein coupled receptor gpr3 to identify appetite control agents |
11/08/2001 | WO2001083806A1 Immunoglobulin binding protein arrays in plant cells |
11/08/2001 | WO2001083783A2 In vivo loading of mhc |
11/08/2001 | WO2001083782A2 Novel proteases |